Clinical trial reportArthritis & rheumatology (Hoboken, N.J.)Published
Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Arthritis & rheumatology (Hoboken, N.J.)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Arthritis, Psoriatic; C-Reactive Protein; Antirheumatic Agents; Antibodies, Monoclonal; Treatment Outcome; Drug Therapy, Combination; Injections, Subcutaneous; Double-Blind Method; Adult; Middle Aged; Female
- PubMed ID
- 41878957
- PubMed Central ID
- PMC13712541
- Open access
- Yes, open
- Added to directory
- Source checked